Biotech

Aurinia Closes US$191.7 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common Shares

Aurinia Closes US$191.7 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common Shares Original press release here VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the ...

Appili Therapeutics Names Dr. Armand Balboni as Chief Executive Officer

Appili Therapeutics Names Dr. Armand Balboni as Chief Executive Officer Original press release here HALIFAX, Nova Scotia, December 2, 2019 – Appili Therapeutics Inc. (TSXV: APLI) (the “Company” or “Appili”), a clinical stage biopharmaceutical company developing anti-infective drug and ...

Q3 2019 Share Price Performance

Q3 2019 Share Price Performance Healthcare Stocks – Choppy Stalling Pattern Continues In this blog post, the Bloom Burton equity research team summarizes the performance of the Canadian healthcare sector during 3Q-2019, and provides commentary on select stock movements and overall market trends. ...

Triumvira Immunologics Announces Fast Track Designation for Its First TAC T-Cell Therapeutic Product Candidate: TAC01-CD19

Triumvira Immunologics Announces Fast Track Designation for Its First TAC T-Cell Therapeutic Product Candidate: TAC01-CD19 Original press release here Designation Confirms Significant Unmet Need Remains in DLBCLNovember 07, 2019 07:00 AM Eastern Standard Time AUSTIN, Texas & HAMILTON, Ontario–(BU ...

2020 could be a breakout year for Tetra Bio-Pharma, says Paradigm Capital

Cannabis biopharmaceutical company Tetra Bio-Pharma (Tetra Bio-Pharma Stock Quote, Chart, News TSXV:TBP) is setting up for a big year in 2020, according to Paradigm Capital analyst Corey Hammill, who reviewed the company’s latest news release in an update to clients on Tuesday. There’s no way o ...

MindBeacon Group announces Series A follow-on investment round led by Green Shield Canada has exceeded $18 million

MindBeacon Group announces Series A follow-on investment round led by Green Shield Canada has exceeded $18 million Original press release here Investment will accelerate the company’s entrance into new markets and dramatic expansion of its digital mental healthcare platform to extend SaaS capacit ...

Poul Sorensen Receives the 2019 Bloom Burton Award

Poul Sorensen Receives the 2019 Bloom Burton Award September 30, 2019 TORONTO–(BUSINESS WIRE) — Bloom Burton & Co. (“Bloom Burton”) is pleased to announce Dr. Poul Sorensen as the recipient of the 2019 Bloom Burton Award. Dr. Sorensen is a Distinguished Scientist at the BC Cancer Agency and ...

The Influence of Emerging Markets on the Pharmaceutical Industry

This paper was originally published by  Maya Tannoury and Zouhair Attieh in Current Therapeutic Research under a creative commons license. Abstract Emerging markets represent an exceptional opportunity for the pharmaceutical… The post The Influence of Emerging Markets on the Pharmaceutical Indus ...

Alternative Data for Biotechnology and Pharmaceutical Financial Modeling and Time Series Analysis

BUILD AND BACKTEST YOUR FINANCIAL MODELS WITH ANNOTATED DRUG PATENTS, SALES, AND LITIGATION   Apply your financial models to our data Keep your models fresh with our live patent data… The post Alternative Data for Biotechnology and Pharmaceutical Financial Modeling and Time Series Analysis appea ...

BELLUS Health Closes US$70 Million Public Offering of Common Shares in Canada and the United States

BELLUS Health Closes US$70 Million Public Offering of Common Shares in Canada and the United States Original press release here LAVAL, Quebec–(BUSINESS WIRE)–Sep. 9, 2019– BELLUS Health Inc. (“BELLUS Health” or the “Company”) (Nasdaq: BLU; TSX: BLU), a clinical-stage biopharmaceuti ...